Charles W. Newton - Chief Financial Officer at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

Charles W. Newton - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by Charles W. Newton for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15.3K $161K $10.54 Aug 21, 2025 Direct
Common Stock 10K $110K $10.98 Aug 20, 2025 Co-grantor and Co-trustee
Option (right to buy) 56.3K Feb 10, 2025 Direct Common Stock

Transactions reported by Charles W. Newton for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.